Clinical Trials Browser

Mouth Neoplasms × camrelizumab × Head & Neck × Clear all

NCT07400094 2026-02-10

NeoCamre-HN

Phase 2 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms, Mouth Neoplasms

NCT04393506 2023-11-22

Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma

Phase 1 Completed

Mouth Neoplasms